Female sexual dysfunction andurinary discomfort
We observed a group of patients (35 women of mean age around 30). Within 7 weeks of a1-blocker (doxazosin 0,5–4 mg daily in combination with M-anticholinergic (trospium chloride 45 mg per day) therapy was conducted. Clinical picture of micturition disorders, quality of life and sexual activity of wo...
Main Authors: | V V Danilov, S A Luchinskiy, T I Danilova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IP Berlin A.V.
2013-06-01
|
Series: | Гинекология |
Subjects: | |
Online Access: | https://gynecology.orscience.ru/2079-5831/article/view/28233 |
Similar Items
-
The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study
by: A. Zachariou, et al.
Published: (2018-06-01) -
An overlooked effect of systemic anticholinergics: alteration on accommodation amplitude
by: Mehmet Ali Sekeroglu, et al.
Published: (2016-05-01) -
Impact of Overactive Bladder Syndrome on Female Sexual Function
by: Serdar Toksöz, et al.
Published: (2015-12-01) -
Role of botulinum toxin-A in management of refractory idiopathic detrusor overactive bladder: Single center experience
by: N K Mohanty, et al.
Published: (2008-01-01) -
Management of Hypertension with Female Sexual Dysfunction
by: Qing Zhong, et al.
Published: (2022-05-01)